Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation for Breast Cancer Patients With Bone Only Metastases
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
Primary objectives:
- To determine the time to progression in subjects with breast cancer metastatic to bone only
treated with 153Sm-EDTMP and Autologous Peripheral Blood Stem Cell Transplantation (PBSCT).
Secondary objectives:
- To determine the overall survival at one year.
- To determine the efficacy of 153Sm-EDTMP at 6 months.
- To assess pain in subjects treated with 153Sm-EDTMP.
- To determine the safety of 153Sm-EDTMP.